APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Trigger Point Injections Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Trigger Point Injections Drugs Industry Growth and Trends Forecast to 2032

Report ID 174043230129 December 2025123 pages

Choose your research edition.

Industry ResearchTrigger Point Injections Drugs Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Trigger Point Injections Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Trigger Point Injections Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Trigger Point Injections Drugs Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Trigger Point Injections Drugs Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

According to APO Research, the global Trigger Point Injections Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Trigger Point Injections Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Trigger Point Injections Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Trigger Point Injections Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Trigger Point Injections Drugs market include Allergan, Anuh Pharma, Axplora, Boehringer Ingelheim, Bristol Myers Squibb, Cipla, EUROAPI, GlaxoSmithKline and Hospira, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Trigger Point Injections Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Trigger Point Injections Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Trigger Point Injections Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Trigger Point Injections Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Trigger Point Injections Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Trigger Point Injections Drugs Market by Company

Allergan

Anuh Pharma

Axplora

Boehringer Ingelheim

Bristol Myers Squibb

Cipla

EUROAPI

GlaxoSmithKline

Hospira

Hovione

Ipsen

Regeneron Pharmaceuticals

Steroid

Symbiotec Pharmalab

Teva Pharmaceuticals

Wellona Pharma

Zimmer Biomet

Bayer

GSK

Pfizer

Mylan

Sun Pharmaceutical

Trigger Point Injections Drugs Segment by Type

Botulinum Toxin (Botox)

Corticosteroids

Local Anesthetics

Platelet-Rich Plasma (PRP)

Other Agents

Trigger Point Injections Drugs Segment by Application

Surgical

Medical Diagnosis

Intensive Care Area (ICU)

Trigger Point Injections Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Trigger Point Injections Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Trigger Point Injections Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Trigger Point Injections Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Trigger Point Injections Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Trigger Point Injections Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Trigger Point Injections Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Trigger Point Injections Drugs Market Share by Region (2021-2026) Table 4. Global Trigger Point Injections Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Trigger Point Injections Drugs Market Share by Region (2027-2032) Table 6. Global Trigger Point Injections Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Trigger Point Injections Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Trigger Point Injections Drugs Market Size Share by Type (2021-2026) Table 9. Global Trigger Point Injections Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Trigger Point Injections Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Trigger Point Injections Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Trigger Point Injections Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Trigger Point Injections Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Trigger Point Injections Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Trigger Point Injections Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Trigger Point Injections Drugs Market Size Share by Application (2021-2026) Table 24. Global Trigger Point Injections Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Trigger Point Injections Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Trigger Point Injections Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Trigger Point Injections Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Trigger Point Injections Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Trigger Point Injections Drugs Industry Trends Table 37. Trigger Point Injections Drugs Industry Drivers Table 38. Trigger Point Injections Drugs Industry Opportunities and Challenges Table 39. Trigger Point Injections Drugs Industry Restraints Table 40. Global Trigger Point Injections Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Trigger Point Injections Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Trigger Point Injections Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Trigger Point Injections Drugs Key Company Headquarters & Area Served Table 44. Global Trigger Point Injections Drugs Company, Product Type & Application Table 45. Global Trigger Point Injections Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Trigger Point Injections Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Allergan Company Information Table 49. Allergan Business Overview Table 50. Allergan Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Allergan Trigger Point Injections Drugs Product Portfolio Table 52. Allergan Recent Development Table 53. Anuh Pharma Company Information Table 54. Anuh Pharma Business Overview Table 55. Anuh Pharma Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Anuh Pharma Trigger Point Injections Drugs Product Portfolio Table 57. Anuh Pharma Recent Development Table 58. Axplora Company Information Table 59. Axplora Business Overview Table 60. Axplora Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Axplora Trigger Point Injections Drugs Product Portfolio Table 62. Axplora Recent Development Table 63. Boehringer Ingelheim Company Information Table 64. Boehringer Ingelheim Business Overview Table 65. Boehringer Ingelheim Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Boehringer Ingelheim Trigger Point Injections Drugs Product Portfolio Table 67. Boehringer Ingelheim Recent Development Table 68. Bristol Myers Squibb Company Information Table 69. Bristol Myers Squibb Business Overview Table 70. Bristol Myers Squibb Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bristol Myers Squibb Trigger Point Injections Drugs Product Portfolio Table 72. Bristol Myers Squibb Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Cipla Trigger Point Injections Drugs Product Portfolio Table 77. Cipla Recent Development Table 78. EUROAPI Company Information Table 79. EUROAPI Business Overview Table 80. EUROAPI Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. EUROAPI Trigger Point Injections Drugs Product Portfolio Table 82. EUROAPI Recent Development Table 83. GlaxoSmithKline Company Information Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline Trigger Point Injections Drugs Product Portfolio Table 87. GlaxoSmithKline Recent Development Table 88. Hospira Company Information Table 89. Hospira Business Overview Table 90. Hospira Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Hospira Trigger Point Injections Drugs Product Portfolio Table 92. Hospira Recent Development Table 93. Hovione Company Information Table 94. Hovione Business Overview Table 95. Hovione Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Hovione Trigger Point Injections Drugs Product Portfolio Table 97. Hovione Recent Development Table 98. Ipsen Company Information Table 99. Ipsen Business Overview Table 100. Ipsen Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Ipsen Trigger Point Injections Drugs Product Portfolio Table 102. Ipsen Recent Development Table 103. Regeneron Pharmaceuticals Company Information Table 104. Regeneron Pharmaceuticals Business Overview Table 105. Regeneron Pharmaceuticals Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Regeneron Pharmaceuticals Trigger Point Injections Drugs Product Portfolio Table 107. Regeneron Pharmaceuticals Recent Development Table 108. Steroid Company Information Table 109. Steroid Business Overview Table 110. Steroid Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Steroid Trigger Point Injections Drugs Product Portfolio Table 112. Steroid Recent Development Table 113. Symbiotec Pharmalab Company Information Table 114. Symbiotec Pharmalab Business Overview Table 115. Symbiotec Pharmalab Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Symbiotec Pharmalab Trigger Point Injections Drugs Product Portfolio Table 117. Symbiotec Pharmalab Recent Development Table 118. Teva Pharmaceuticals Company Information Table 119. Teva Pharmaceuticals Business Overview Table 120. Teva Pharmaceuticals Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Teva Pharmaceuticals Trigger Point Injections Drugs Product Portfolio Table 122. Teva Pharmaceuticals Recent Development Table 123. Wellona Pharma Company Information Table 124. Wellona Pharma Business Overview Table 125. Wellona Pharma Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Wellona Pharma Trigger Point Injections Drugs Product Portfolio Table 127. Wellona Pharma Recent Development Table 128. Zimmer Biomet Company Information Table 129. Zimmer Biomet Business Overview Table 130. Zimmer Biomet Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Zimmer Biomet Trigger Point Injections Drugs Product Portfolio Table 132. Zimmer Biomet Recent Development Table 133. Bayer Company Information Table 134. Bayer Business Overview Table 135. Bayer Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Bayer Trigger Point Injections Drugs Product Portfolio Table 137. Bayer Recent Development Table 138. GSK Company Information Table 139. GSK Business Overview Table 140. GSK Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. GSK Trigger Point Injections Drugs Product Portfolio Table 142. GSK Recent Development Table 143. Pfizer Company Information Table 144. Pfizer Business Overview Table 145. Pfizer Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Pfizer Trigger Point Injections Drugs Product Portfolio Table 147. Pfizer Recent Development Table 148. Mylan Company Information Table 149. Mylan Business Overview Table 150. Mylan Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Mylan Trigger Point Injections Drugs Product Portfolio Table 152. Mylan Recent Development Table 153. Sun Pharmaceutical Company Information Table 154. Sun Pharmaceutical Business Overview Table 155. Sun Pharmaceutical Trigger Point Injections Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Sun Pharmaceutical Trigger Point Injections Drugs Product Portfolio Table 157. Sun Pharmaceutical Recent Development Table 158. North America Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Trigger Point Injections Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Trigger Point Injections Drugs Market Share by Country (2021-2026) Table 161. North America Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Trigger Point Injections Drugs Market Share Forecast by Country (2027-2032) Table 163. Europe Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Trigger Point Injections Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Trigger Point Injections Drugs Market Share by Country (2021-2026) Table 166. Europe Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Trigger Point Injections Drugs Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Trigger Point Injections Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Trigger Point Injections Drugs Market Share by Country (2021-2026) Table 171. Asia-Pacific Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Trigger Point Injections Drugs Market Share Forecast by Country (2027-2032) Table 173. Latin America Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Latin America Trigger Point Injections Drugs Market Size by Country (2021-2026) & (US$ Million) Table 175. Latin America Trigger Point Injections Drugs Market Share by Country (2021-2026) Table 176. Latin America Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Latin America Trigger Point Injections Drugs Market Share Forecast by Country (2027-2032) Table 178. Middle East & Africa Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East & Africa Trigger Point Injections Drugs Market Share by Country (2021-2026) Table 181. Middle East & Africa Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East & Africa Trigger Point Injections Drugs Market Share Forecast by Country (2027-2032) Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Trigger Point Injections Drugs Product Image Figure 3. Global Trigger Point Injections Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Trigger Point Injections Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Trigger Point Injections Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Trigger Point Injections Drugs Market Share by Region (2021-2032) Figure 7. North America Trigger Point Injections Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Trigger Point Injections Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Trigger Point Injections Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Trigger Point Injections Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Trigger Point Injections Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Botulinum Toxin (Botox) Image Figure 13. Global Botulinum Toxin (Botox) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Corticosteroids Image Figure 15. Global Corticosteroids Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Local Anesthetics Image Figure 17. Global Local Anesthetics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Platelet-Rich Plasma (PRP) Image Figure 19. Global Platelet-Rich Plasma (PRP) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Other Agents Image Figure 21. Global Other Agents Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Trigger Point Injections Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Trigger Point Injections Drugs Market Share by Type 2025 VS 2032 Figure 24. North America Trigger Point Injections Drugs Market Size Share by Type (2021-2032) Figure 25. Europe Trigger Point Injections Drugs Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Trigger Point Injections Drugs Market Size Share by Type (2021-2032) Figure 27. Latin America Trigger Point Injections Drugs Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Trigger Point Injections Drugs Market Size Share by Type (2021-2032) Figure 29. Surgical Image Figure 30. Global Surgical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Medical Diagnosis Image Figure 32. Global Medical Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Intensive Care Area (ICU) Image Figure 34. Global Intensive Care Area (ICU) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Trigger Point Injections Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Trigger Point Injections Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Trigger Point Injections Drugs Market Size Share by Application (2021-2032) Figure 38. Europe Trigger Point Injections Drugs Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Trigger Point Injections Drugs Market Size Share by Application (2021-2032) Figure 40. Latin America Trigger Point Injections Drugs Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Trigger Point Injections Drugs Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Trigger Point Injections Drugs Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Trigger Point Injections Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Trigger Point Injections Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Trigger Point Injections Drugs Market Share by Country (2021-2032) Figure 47. Europe Trigger Point Injections Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Trigger Point Injections Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Trigger Point Injections Drugs Market Share by Country (2021-2032) Figure 50. Asia-Pacific Trigger Point Injections Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Trigger Point Injections Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Trigger Point Injections Drugs Market Share by Country (2021-2032) Figure 53. Latin America Trigger Point Injections Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Trigger Point Injections Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Trigger Point Injections Drugs Market Share by Country (2021-2032) Figure 56. Middle East & Africa Trigger Point Injections Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Trigger Point Injections Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Trigger Point Injections Drugs Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Botulinum Toxin (Botox)
  • Corticosteroids
  • Local Anesthetics
  • Platelet-Rich Plasma (PRP)
  • Other Agents
Applications
  • Surgical
  • Medical Diagnosis
  • Intensive Care Area (ICU)
Companies covered
  • Allergan
  • Anuh Pharma
  • Axplora
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Cipla
  • EUROAPI
  • GlaxoSmithKline
  • Hospira
  • Hovione
  • Ipsen
  • Regeneron Pharmaceuticals
  • Steroid
  • Symbiotec Pharmalab
  • Teva Pharmaceuticals
  • Wellona Pharma
  • Zimmer Biomet
  • Bayer
  • GSK
  • Pfizer
  • Mylan
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Trigger Point Injections Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Trigger Point Injections Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Trigger Point Injections Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Trigger Point Injections Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Trigger Point Injections Drugs Market Size (2021-2032)
  8. 1.5.1 North America Trigger Point Injections Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Trigger Point Injections Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Trigger Point Injections Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Trigger Point Injections Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Trigger Point Injections Drugs Market Size Growth Rate (2021-2032)
2 Trigger Point Injections Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Botulinum Toxin (Botox)
  3. 2.1.2 Corticosteroids
  4. 2.1.3 Local Anesthetics
  5. 2.1.4 Platelet-Rich Plasma (PRP)
  6. 2.1.5 Other Agents
  7. 2.2 Global Trigger Point Injections Drugs Market Size by Type
  8. 2.2.1 Global Trigger Point Injections Drugs Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Trigger Point Injections Drugs Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Trigger Point Injections Drugs Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Trigger Point Injections Drugs Market Size by Regions
  12. 2.3.1 North America Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Type (2021-2026)
3 Trigger Point Injections Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Surgical
  3. 3.1.2 Medical Diagnosis
  4. 3.1.3 Intensive Care Area (ICU)
  5. 3.2 Global Trigger Point Injections Drugs Market Size by Application
  6. 3.2.1 Global Trigger Point Injections Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Trigger Point Injections Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Trigger Point Injections Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Trigger Point Injections Drugs Market Size by Regions
  10. 3.3.1 North America Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Trigger Point Injections Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Trigger Point Injections Drugs Industry Trends
  2. 4.2 Trigger Point Injections Drugs Industry Drivers
  3. 4.3 Trigger Point Injections Drugs Industry Opportunities and Challenges
  4. 4.4 Trigger Point Injections Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Trigger Point Injections Drugs Revenue (2021-2026)
  2. 5.2 Global Trigger Point Injections Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Trigger Point Injections Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Trigger Point Injections Drugs Company, Product Type & Application
  5. 5.5 Global Trigger Point Injections Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Trigger Point Injections Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Trigger Point Injections Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Trigger Point Injections Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Allergan
  2. 6.1.1 Allergan Company Information
  3. 6.1.2 Allergan Business Overview
  4. 6.1.3 Allergan Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Allergan Trigger Point Injections Drugs Product Portfolio
  6. 6.1.5 Allergan Recent Developments
  7. 6.2 Anuh Pharma
  8. 6.2.1 Anuh Pharma Company Information
  9. 6.2.2 Anuh Pharma Business Overview
  10. 6.2.3 Anuh Pharma Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Anuh Pharma Trigger Point Injections Drugs Product Portfolio
  12. 6.2.5 Anuh Pharma Recent Developments
  13. 6.3 Axplora
  14. 6.3.1 Axplora Company Information
  15. 6.3.2 Axplora Business Overview
  16. 6.3.3 Axplora Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Axplora Trigger Point Injections Drugs Product Portfolio
  18. 6.3.5 Axplora Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Trigger Point Injections Drugs Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
  25. 6.5 Bristol Myers Squibb
  26. 6.5.1 Bristol Myers Squibb Company Information
  27. 6.5.2 Bristol Myers Squibb Business Overview
  28. 6.5.3 Bristol Myers Squibb Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bristol Myers Squibb Trigger Point Injections Drugs Product Portfolio
  30. 6.5.5 Bristol Myers Squibb Recent Developments
  31. 6.6 Cipla
  32. 6.6.1 Cipla Company Information
  33. 6.6.2 Cipla Business Overview
  34. 6.6.3 Cipla Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Cipla Trigger Point Injections Drugs Product Portfolio
  36. 6.6.5 Cipla Recent Developments
  37. 6.7 EUROAPI
  38. 6.7.1 EUROAPI Company Information
  39. 6.7.2 EUROAPI Business Overview
  40. 6.7.3 EUROAPI Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 EUROAPI Trigger Point Injections Drugs Product Portfolio
  42. 6.7.5 EUROAPI Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Trigger Point Injections Drugs Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Hospira
  50. 6.9.1 Hospira Company Information
  51. 6.9.2 Hospira Business Overview
  52. 6.9.3 Hospira Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Hospira Trigger Point Injections Drugs Product Portfolio
  54. 6.9.5 Hospira Recent Developments
  55. 6.10 Hovione
  56. 6.10.1 Hovione Company Information
  57. 6.10.2 Hovione Business Overview
  58. 6.10.3 Hovione Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Hovione Trigger Point Injections Drugs Product Portfolio
  60. 6.10.5 Hovione Recent Developments
  61. 6.11 Ipsen
  62. 6.11.1 Ipsen Company Information
  63. 6.11.2 Ipsen Business Overview
  64. 6.11.3 Ipsen Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Ipsen Trigger Point Injections Drugs Product Portfolio
  66. 6.11.5 Ipsen Recent Developments
  67. 6.12 Regeneron Pharmaceuticals
  68. 6.12.1 Regeneron Pharmaceuticals Company Information
  69. 6.12.2 Regeneron Pharmaceuticals Business Overview
  70. 6.12.3 Regeneron Pharmaceuticals Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Regeneron Pharmaceuticals Trigger Point Injections Drugs Product Portfolio
  72. 6.12.5 Regeneron Pharmaceuticals Recent Developments
  73. 6.13 Steroid
  74. 6.13.1 Steroid Company Information
  75. 6.13.2 Steroid Business Overview
  76. 6.13.3 Steroid Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Steroid Trigger Point Injections Drugs Product Portfolio
  78. 6.13.5 Steroid Recent Developments
  79. 6.14 Symbiotec Pharmalab
  80. 6.14.1 Symbiotec Pharmalab Company Information
  81. 6.14.2 Symbiotec Pharmalab Business Overview
  82. 6.14.3 Symbiotec Pharmalab Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Symbiotec Pharmalab Trigger Point Injections Drugs Product Portfolio
  84. 6.14.5 Symbiotec Pharmalab Recent Developments
  85. 6.15 Teva Pharmaceuticals
  86. 6.15.1 Teva Pharmaceuticals Company Information
  87. 6.15.2 Teva Pharmaceuticals Business Overview
  88. 6.15.3 Teva Pharmaceuticals Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Teva Pharmaceuticals Trigger Point Injections Drugs Product Portfolio
  90. 6.15.5 Teva Pharmaceuticals Recent Developments
  91. 6.16 Wellona Pharma
  92. 6.16.1 Wellona Pharma Company Information
  93. 6.16.2 Wellona Pharma Business Overview
  94. 6.16.3 Wellona Pharma Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Wellona Pharma Trigger Point Injections Drugs Product Portfolio
  96. 6.16.5 Wellona Pharma Recent Developments
  97. 6.17 Zimmer Biomet
  98. 6.17.1 Zimmer Biomet Company Information
  99. 6.17.2 Zimmer Biomet Business Overview
  100. 6.17.3 Zimmer Biomet Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Zimmer Biomet Trigger Point Injections Drugs Product Portfolio
  102. 6.17.5 Zimmer Biomet Recent Developments
  103. 6.18 Bayer
  104. 6.18.1 Bayer Company Information
  105. 6.18.2 Bayer Business Overview
  106. 6.18.3 Bayer Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Bayer Trigger Point Injections Drugs Product Portfolio
  108. 6.18.5 Bayer Recent Developments
  109. 6.19 GSK
  110. 6.19.1 GSK Company Information
  111. 6.19.2 GSK Business Overview
  112. 6.19.3 GSK Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 GSK Trigger Point Injections Drugs Product Portfolio
  114. 6.19.5 GSK Recent Developments
  115. 6.20 Pfizer
  116. 6.20.1 Pfizer Company Information
  117. 6.20.2 Pfizer Business Overview
  118. 6.20.3 Pfizer Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Pfizer Trigger Point Injections Drugs Product Portfolio
  120. 6.20.5 Pfizer Recent Developments
  121. 6.21 Mylan
  122. 6.21.1 Mylan Company Information
  123. 6.21.2 Mylan Business Overview
  124. 6.21.3 Mylan Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Mylan Trigger Point Injections Drugs Product Portfolio
  126. 6.21.5 Mylan Recent Developments
  127. 6.22 Sun Pharmaceutical
  128. 6.22.1 Sun Pharmaceutical Company Information
  129. 6.22.2 Sun Pharmaceutical Business Overview
  130. 6.22.3 Sun Pharmaceutical Trigger Point Injections Drugs Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Sun Pharmaceutical Trigger Point Injections Drugs Product Portfolio
  132. 6.22.5 Sun Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Trigger Point Injections Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Trigger Point Injections Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Trigger Point Injections Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Trigger Point Injections Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Trigger Point Injections Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Trigger Point Injections Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Trigger Point Injections Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst